Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shanghai Conant Optical CoHKSE:02276 -5.46%78 EV-to-FCF is 66.62 as of Aug. 19, 2026, which is 62% above its 10-year median of 41.19. GuruFocus rates HKSE:02276 with a GF Score™ of 78/100 and a GF Value™ of HK$15.68 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 407 Medical Devices & Instruments companies, Shanghai Conant Optical Co ranks worse than 82.31% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Shanghai Conant Optical Co's Enterprise Value is HK$17,749 Mil.
Shanghai Conant Optical Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was HK$266 Mil. Therefore, Shanghai Conant Optical Co's EV-to-FCF for today is 66.62.
The historical rank and industry rank for Shanghai Conant Optical Co's EV-to-FCF or its related term are showing as below:
HKSE:02276'
s EV-to-FCF Range Over the Past 10 Years
Min: 7.16 Med: 41.19 Max: 106.51
Current: 66.62
During the past 8 years, the highest EV-to-FCF of Shanghai Conant Optical Co was 106.51. The lowest was 7.16. And the median was 41.19.
HKSE:02276's EV-to-FCF is ranked worse than 82.31% of 407
companies
in the Medical Devices & Instruments industry
Industry Median: 23.8
vs HKSE:02276: 66.62
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Shanghai Conant Optical Co (HKSE:02276) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Shanghai Conant Optical Co's PE Ratio (TTM) for today is calculated as:
Shanghai Conant Optical Co's share price for today is HK$38.44.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Shanghai Conant Optical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was HK$1.403.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Shanghai Conant Optical Co EV-to-FCF Related Terms
Shanghai Conant Optical Co EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02276 vs ISRG, BDX, MDLN: EV-to-FCF Comparison
For the Medical Instruments & Supplies subindustry, Shanghai Conant Optical Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Conant Optical Co EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shanghai Conant Optical Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Shanghai Conant Optical Co's EV-to-FCF falls into.
Shanghai Conant Optical Co's current Enterprise Value is HK$17,749 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Shanghai Conant Optical Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was HK$266 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Conant Optical Co (HKSE:02276) has a EV-to-FCF of 66.62 as of Aug. 19, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Shanghai Conant Optical Co and its competitors. This is 62% above median its historical median of 41.19. Over the past decade, Shanghai Conant Optical Co's EV-to-FCF has ranged from 7.16 to 106.51. According to the industry distribution chart, Shanghai Conant Optical Co ranks #335 out of 407 companies in the Medical Devices & Instruments industry, placing it in the top 82.3%.
Is Shanghai Conant Optical Co's EV-to-FCF too high?
Shanghai Conant Optical Co's current EV-to-FCF of 66.62 is 62% above median its 10-year median of 41.19. Over the past 10 years, this metric has ranged from a low of 7.16 to a high of 106.51. The Medical Devices & Instruments industry median EV-to-FCF is 23.80. Shanghai Conant Optical Co's value of 66.62 is 179.9% above this industry median. Based on the distribution chart, Shanghai Conant Optical Co ranks #335 out of 407 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Shanghai Conant Optical Co has a GF Score™ of 78/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Conant Optical Co's EV-to-FCF compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Shanghai Conant Optical Co ranks #335 out of 407 companies for EV-to-FCF. This places Shanghai Conant Optical Co in the lower half of its industry. The industry median EV-to-FCF is 23.80. Shanghai Conant Optical Co's value of 66.62 is 179.9% above this benchmark. Historically, Shanghai Conant Optical Co's own EV-to-FCF has ranged from 7.16 to 106.51 over the past decade. While the company's 10-year median is 41.19 vs. the industry median of 23.80, Shanghai Conant Optical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.80, based on 407 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Conant Optical Co's current EV-to-FCF of 66.62 is 179.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Shanghai Conant Optical Co and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Conant Optical Co's current EV-to-FCF is 66.62, which is 62% above median its own 10-year median of 41.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Conant Optical Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Conant Optical Co (HKSE:02276) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$15.68, compared to a current price of HK$38.44 — trading 145.2% above its estimated fair value. The current EV-to-FCF is 66.62, which is 62% above median its 10-year median of 41.19 and 179.9% above the Medical Devices & Instruments industry median of 23.80. Shanghai Conant Optical Co's overall GF Score™ is 78/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Shanghai Conant Optical Co (HKSE:02276), the current EV-to-FCF is 66.62 as of Aug. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Conant Optical Co (HKSE:02276) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Conant Optical Co stock appears to be overvalued.
The current stock price of HK$38.44 is trading 145.2% above its estimated GF Value™ of HK$15.68.
GuruFocus considers Shanghai Conant Optical Co to be Significantly Overvalued.
Key valuation signals for HKSE:02276:
EV-to-FCF: 66.62 (62% above median its 10-year median of 41.19)
GF Value™: HK$15.68 vs. price of HK$38.44 (145.2% above fair value)
Industry Position: 179.9% above the Medical Devices & Instruments median (#335 of 407)
No single metric tells the full story. See the HKSE:02276 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AddressNo. 1-42, Lane 83, Hongxiang North Road, 4th Floor, Building 35, Lin-gang Special Area, China (Shanghai) Pilot Free Trade Zone China, Shanghai, CHN
Shanghai Conant Optical Co Ltd is a resin spectacle lens manufacturer in China. The company offers a wide range of resin spectacle lenses to its customers including standardized lenses and customized lenses. The spectacle lenses are also tinted, coated, or cast with various films or coatings for added functionality, such as polarised, photochromic, blue-ray blocking, anti-scratch, anti-reflection, and anti-smudge. Geographically, the company generates a majority of its revenue from Mainland China and the rest from the Americas, Europe, Oceania, Africa, and Asia (except for mainland China). It products include: CR-Freeform; CoMax; AC lens; Gaming Glassed, Antifog Lens; MyoEase; Polycarbonate lens; Photochromic coating lens; SingleVision Finished Lens; and Others.
78GF Score
Get the complete analysis for HKSE:02276
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02276 has been successfully added to your 
